Jamieson Wellness (TSE:JWEL - Get Free Report) had its target price lifted by stock analysts at BMO Capital Markets from C$42.00 to C$46.00 in a research note issued to investors on Thursday,BayStreet.CA reports. BMO Capital Markets' price target would suggest a potential upside of 21.98% from the stock's current price.
A number of other research firms have also recently commented on JWEL. TD Securities increased their target price on Jamieson Wellness from C$40.00 to C$42.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. National Bankshares increased their price objective on shares of Jamieson Wellness from C$36.50 to C$42.00 in a research report on Monday, November 25th. Finally, Royal Bank of Canada lifted their target price on shares of Jamieson Wellness from C$37.00 to C$38.00 in a report on Friday, November 8th.
Check Out Our Latest Stock Analysis on JWEL
Jamieson Wellness Stock Performance
JWEL stock remained flat at C$37.71 on Thursday. The company had a trading volume of 95,606 shares, compared to its average volume of 60,298. The company has a 50-day moving average price of C$35.62 and a two-hundred day moving average price of C$32.69. The stock has a market capitalization of C$1.56 billion, a price-to-earnings ratio of 43.85 and a beta of 0.63. The company has a current ratio of 3.21, a quick ratio of 1.08 and a debt-to-equity ratio of 92.76. Jamieson Wellness has a 12 month low of C$23.98 and a 12 month high of C$38.20.
Insiders Place Their Bets
In other Jamieson Wellness news, Senior Officer Regan Stewart sold 1,300 shares of the business's stock in a transaction on Thursday, December 12th. The shares were sold at an average price of C$37.84, for a total transaction of C$49,192.00. Insiders sold 11,237 shares of company stock worth $407,455 in the last three months. 0.26% of the stock is owned by company insiders.
Jamieson Wellness Company Profile
(
Get Free Report)
Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.
Further Reading
Before you consider Jamieson Wellness, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jamieson Wellness wasn't on the list.
While Jamieson Wellness currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
